Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening — Stella

Recruiting

Back to Glioblastoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Austria

AKH Vienna, Department for Internal Medicine I, Oncology, Vienna, State of Vienna

Key details

Sponsor

Medical University of Vienna

Enrollment target

~240 participants

Started

July 2024

Primary completion

December 2030

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov